Faculty

Institution

Unit

Venue

Hariprasad Gali

Associate Professor

University of Oklahoma

Affiliations

HEALTH SCIENCES CENTER CAMPUS COLLEGES

College of Pharmacy

Hariprasad Gali is currently serving as a College Of Pharmacy Associate Professor at University of Oklahoma.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hariprasad Gali

University of Oklahoma

Associate Professor

You can click a keyword to filter the displayed items

pharmacology radiation oncology chemistry drug discovery oncology medicinal research medicine medicinal chemistry chemical synthesis nuclear medicine tumor targeting cancer treatment enzyme inhibition organic synthesis tumor biology photomedicine medical imaging peptides radiopharmaceutical therapy anti-cancer agents drug targeting synthetic chemistry cancer biology biomedical imaging cancer care pharmaceutical sciences pharmaceutical chemistry drug delivery peptide science cancer imaging pharmacotherapy photodynamic therapy radiation chemistry colorectal cancer bioconjugation peptide synthesis positron emission tomography pancreatic cancer vivo evaluation protein science cellular therapy material chemistry drug analysis clinical chemistry radiation biology radiation application fullerenes radiation therapy dosimetry peptide engineering radiochemical investigations pet renography functionalized water-soluble phosphines biomedical implications sustainable chemistry pharmaceutical nanotechnology novel imaging methods gastrointestinal oncology in vivo systems imaging spectroscopy tissue imaging cancer genomics advanced imaging biological evaluation specific targeting guanylin receptors vivo characterization mouse model biomarker target biocatalysis cationic fullerenes photodynamic killing novel series gastrin-releasing peptide receptors integrin-targeted plga-chitosan nanoparticle lung cancer therapy molecular imaging radiology diagnostic imaging computed tomography

Notable Scholarly Works

Notable Federal Grants

Collaborators

Positron Emission Tomography (Pet) With 18 F-Fga for Diagnosis of Myocardial Infarction in a Coronary Artery Ligation Model. Molecular Imaging (2022)

Vibhudutta AwasthiHariprasad GaliAndria F. HedrickHuining DaVenkateswararao EedaDiwakar Jain

myocardial infarctioncardiologypositron emission tomographymedical imagingrespiratory medicinemolecular imagingradiology

Development of Radiopharmaceuticals for Pet Renography. Journal of Chemical Sciences (2021)

HARIPRASAD GALI

chemical sciencesradiopharmaceutical therapychemistrypet renography

Gnrh Receptor-Activating Autoantibodies in Polycystic Ovary Syndrome: Identification of Functional Epitopes and Development of Epitope Mimetic Inhibitors. Endocrine (2021)

Hongliang LiYankai GuoJielin DengHariprasad GaliElizabeth A. WeedinHeather R. BurksLaTasha B. CraigXichun Yu

reproductive biologyepitope mimetic inhibitorsimmunologyantibody engineeringgynecologyfunctional epitopesendocrine researchreproductive medicinepharmacologypolycystic ovary syndromeendocrinologygnrh receptor-activating autoantibodies

Sars‐Cov‐2 Main Protease Inhibitory Efficacy of Natural Peptidic α‐Hydroxy Amides for Therapeutic Applications of Covid‐19. The FASEB Journal (2021)

Nagendra YarlaGopal PathuriHariprasad GaliSimon TerzyanAnil SinghMarcus ScottiVenkateshwar MadkaChinthalapally Rao

drug targetingtherapeutic applicationspharmacologytherapeutic targetscovid-19infectious diseasespeptide therapeuticspeptidesdrug discoverypharmacotherapyantiviral drugsantiviral therapyvirus researchsars-cov-2antiviral researchmedicineclinical researchenzyme inhibitionclinical therapeutics

Abstract 16: Lta4 Hydrolase Inhibitor Bestatin Prevents Intestinal Tumors in Apc Mutant Rodent Models of Fap. Cancer Research (2020)

Venkateshwar MadkaGopal PathuriHariprasad GaliNandini KumarNagendra Sastri YarlaAnh BaoAdam S. AschChinthalapally V. Rao

anti-cancer agentsdermatologypharmacologytumor biologycancer immunotherapyenzyme inhibitioncancer researchcancer treatmentoncogenesmedicinal researchintestinal tumorsurologycancer managementcancer carecancer biologyclinical researchleukemiacancer genomicsoncology

Abstract 6364: Lfa-9, a Dual Mpges-1 and 5-Lox Inhibitor, Suppresses Colon Cancer Stemness and Inflammogen-Induced Inflammatory Response. Cancer Research (2020)

Nagendra Sastri YarlaGopal PathuriHariprasad GaliVenkateshwar MadkaJanani PanneerselvamParthasarathy ChandrakesanCourtney W. HouchenElizabeth R. GlazeJennifer FoxDavid McCormickChinthalapally V. Rao

dermatologypharmacologycolorectal cancervascular biologytumor biologycolon cancer stemnesscancer researchcancer treatmentmedical mycologyradiation oncologymedicinal researchprostate cancercancer managementcancer carecancer biologyinflammogen-induced inflammatory responseoncologyclinical researchleukemiatherapeutic efficacy

Discovery and Development of a Novel Mpges-1/5-Lox Dual Inhibitor Lfa-9 for Prevention and Treatment of Chronic Inflammatory Diseases. Journal of Inflammation Research (2020)

Nagendra Sastri YarlaGopal PathuriHariprasad GaliSimon TerzyanJanani PanneerselvamParthasarathy ChandrakesanMarcus Tullius ScottiCourtney HouchenVenkateshwar MadkaChinthalapally V Rao

inflammationanti-inflammatoryimmunologypharmacologychronic inflammatory diseases

Lfa‐9, a Selective Inhibitor of Microsomal Prostaglandin Synthase‐1 and 5‐Lipoxygenase: Prevention of Inflammatory and Oncologic Diseases. The FASEB Journal (2020)

Nagendra Sastry YarlaGopal PathuriHariprasad GaliJanani PanneerselvamParthasarathy ChandrakesanVenkateshwar MadkaChinthalapally V. Rao

inflammationselective inhibitorimmunologydermatologypharmacologyoncologic diseasesenzyme inhibitiononcology

Nanoparticles for Targeting of Prostate Cancer. Current Pharmaceutical Design (2020)

Hooman YariHariprasad GaliVibhudutta Awasthi

nanomaterialstumor targetingdrug targetingpharmaceutical sciencesnanomedicinenanotechnologypharmaceuticsprostate cancerpharmacologymedicinepharmaceutical nanotechnologyurologycancer treatmentoncology

Pet Detection of Cerebral Necrosis Using an Infarct-Avid Agent 2-Deoxy-2-[18F]Fluoro-D-Glucaric Acid (Fga) in a Mouse Model of the Brain Stroke. Molecular Imaging and Biology (2020)

Hailey HousonAlexander MdzinarishviliHariprasad GaliEvgeny SidorovVibhudutta Awasthi

neurologyepidemiologymouse modelmolecular imagingneurosciencecerebral necrosisbrain strokepet detectionstroke

1
2
3
4
5
8
10 / page

Hariprasad Gali

Associate Professor

University of Oklahoma

Affiliations

HEALTH SCIENCES CENTER CAMPUS COLLEGES

College of Pharmacy

Hariprasad Gali is currently serving as a College Of Pharmacy Associate Professor at University of Oklahoma.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Hariprasad Gali

University of Oklahoma

Associate Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Positron Emission Tomography (Pet) With 18 F-Fga for Diagnosis of Myocardial Infarction in a Coronary Artery Ligation Model. Molecular Imaging (2022)

Vibhudutta AwasthiHariprasad GaliAndria F. HedrickHuining DaVenkateswararao EedaDiwakar Jain

myocardial infarctioncardiologypositron emission tomographymedical imagingrespiratory medicinemolecular imagingradiology

Development of Radiopharmaceuticals for Pet Renography. Journal of Chemical Sciences (2021)

HARIPRASAD GALI

chemical sciencesradiopharmaceutical therapychemistrypet renography

Gnrh Receptor-Activating Autoantibodies in Polycystic Ovary Syndrome: Identification of Functional Epitopes and Development of Epitope Mimetic Inhibitors. Endocrine (2021)

Hongliang LiYankai GuoJielin DengHariprasad GaliElizabeth A. WeedinHeather R. BurksLaTasha B. CraigXichun Yu

Sars‐Cov‐2 Main Protease Inhibitory Efficacy of Natural Peptidic α‐Hydroxy Amides for Therapeutic Applications of Covid‐19. The FASEB Journal (2021)

Nagendra YarlaGopal PathuriHariprasad GaliSimon TerzyanAnil SinghMarcus ScottiVenkateshwar MadkaChinthalapally Rao

Abstract 16: Lta4 Hydrolase Inhibitor Bestatin Prevents Intestinal Tumors in Apc Mutant Rodent Models of Fap. Cancer Research (2020)

Venkateshwar MadkaGopal PathuriHariprasad GaliNandini KumarNagendra Sastri YarlaAnh BaoAdam S. AschChinthalapally V. Rao

Abstract 6364: Lfa-9, a Dual Mpges-1 and 5-Lox Inhibitor, Suppresses Colon Cancer Stemness and Inflammogen-Induced Inflammatory Response. Cancer Research (2020)

Nagendra Sastri YarlaGopal PathuriHariprasad GaliVenkateshwar MadkaJanani PanneerselvamParthasarathy ChandrakesanCourtney W. HouchenElizabeth R. GlazeJennifer FoxDavid McCormickChinthalapally V. Rao

Discovery and Development of a Novel Mpges-1/5-Lox Dual Inhibitor Lfa-9 for Prevention and Treatment of Chronic Inflammatory Diseases. Journal of Inflammation Research (2020)

Nagendra Sastri YarlaGopal PathuriHariprasad GaliSimon TerzyanJanani PanneerselvamParthasarathy ChandrakesanMarcus Tullius ScottiCourtney HouchenVenkateshwar MadkaChinthalapally V Rao

inflammationanti-inflammatoryimmunologypharmacologychronic inflammatory diseases

Lfa‐9, a Selective Inhibitor of Microsomal Prostaglandin Synthase‐1 and 5‐Lipoxygenase: Prevention of Inflammatory and Oncologic Diseases. The FASEB Journal (2020)

Nagendra Sastry YarlaGopal PathuriHariprasad GaliJanani PanneerselvamParthasarathy ChandrakesanVenkateshwar MadkaChinthalapally V. Rao

inflammationselective inhibitorimmunologydermatologypharmacologyoncologic diseasesenzyme inhibitiononcology

Nanoparticles for Targeting of Prostate Cancer. Current Pharmaceutical Design (2020)

Hooman YariHariprasad GaliVibhudutta Awasthi

nanomaterialstumor targetingdrug targetingpharmaceutical sciencesnanomedicinenanotechnologypharmaceuticsprostate cancerpharmacologymedicinepharmaceutical nanotechnologyurologycancer treatmentoncology

Pet Detection of Cerebral Necrosis Using an Infarct-Avid Agent 2-Deoxy-2-[18F]Fluoro-D-Glucaric Acid (Fga) in a Mouse Model of the Brain Stroke. Molecular Imaging and Biology (2020)

Hailey HousonAlexander MdzinarishviliHariprasad GaliEvgeny SidorovVibhudutta Awasthi

neurologyepidemiologymouse modelmolecular imagingneurosciencecerebral necrosisbrain strokepet detectionstroke

1
2
3
4
5
8
10 / page

Similar Faculty Members

Jamey Weichert

Institution

University of Wisconsin–Madison

oncology

radiation oncology

Carolyn Anderson

Institution

University of Missouri

radiology

nuclear medicine

Timothy Hoffman

Institution

University of Missouri

radiation oncology

oncology

Duane D. Miller

Institution

University of Tennessee Health Science Center

pharmacology

medicinal research

Henry Vanbrocklin

Institution

University of California, San Francisco

nuclear medicine

positron emission tomography

Thomas P. Quinn

Institution

University of Missouri

cancer imaging

oncology

Kevin Burgess

Institution

Texas A&M University

chemistry

organic chemistry

Carolyn Anderson

Institution

University of Pittsburgh

Michael Jung

Institution

University of California, Los Angeles

organic chemistry

synthetic organic chemistry

Charles E. McKenna

Institution

University of Southern California

future medicinal chemistry

medicinal chemistry

Similar Faculty Members

Jamey Weichert

Institution

University of Wisconsin–Madison

oncology

radiation oncology

Carolyn Anderson

Institution

University of Missouri

radiology

nuclear medicine

Timothy Hoffman

Institution

University of Missouri

radiation oncology

oncology

Duane D. Miller

Institution

University of Tennessee Health Science Center

pharmacology

medicinal research

Henry Vanbrocklin

Institution

University of California, San Francisco

nuclear medicine

positron emission tomography

Thomas P. Quinn

Institution

University of Missouri

cancer imaging

oncology

Kevin Burgess

Institution

Texas A&M University

chemistry

organic chemistry

Carolyn Anderson

Institution

University of Pittsburgh

Michael Jung

Institution

University of California, Los Angeles

organic chemistry

synthetic organic chemistry

Charles E. McKenna

Institution

University of Southern California

future medicinal chemistry

medicinal chemistry